Aladdin Healthcare Technologies SE Announces the Appointment of David C. Rubinsztein as Chief Scientific Advisor
February 07, 2020 at 03:33 pm IST
Aladdin Healthcare Technologies SE announced that Professor David C. Rubinsztein has been appointed as Chief Scientific Advisor. David is the Deputy Director of the Cambridge University Institute of Medical Research, Professor of Molecular Neurogenetics and Wellcome Trust Principal Research Fellow. His research interests are in autophagy and neurodegeneration.